His primary areas of investigation include Internal medicine, Alzheimer's disease, Immunology, Disease and Genetics. The various areas that Elio Scarpini examines in his Internal medicine study include Gastroenterology, Endocrinology, Oncology and Pathology. His Alzheimer's disease research incorporates themes from Amyloid beta, Central nervous system disease, Neuroscience, Degenerative disease and Dementia.
His research in Immunology tackles topics such as Cerebrospinal fluid which are related to areas like Neurodegeneration. His work focuses on many connections between Disease and other disciplines, such as Pharmacology, that overlap with his field of interest in Bioinformatics. His studies in Genetics integrate themes in fields like Apolipoprotein E and Case-control study.
Elio Scarpini focuses on Internal medicine, Disease, Pathology, Frontotemporal dementia and Genetics. His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Endocrinology and Oncology. Elio Scarpini interconnects Gene, Immunology and Bioinformatics in the investigation of issues within Disease.
His Frontotemporal dementia study combines topics in areas such as Neuroscience and Atrophy. His Allele study combines topics from a wide range of disciplines, such as Odds ratio, Apolipoprotein E and Genotype. Elio Scarpini combines topics linked to Degenerative disease with his work on Alzheimer's disease.
His primary scientific interests are in Frontotemporal dementia, Disease, Internal medicine, Dementia and Pathology. His Frontotemporal dementia research integrates issues from Neuroimaging, Neuroscience, Atrophy and Age of onset. His Disease study focuses on Frontotemporal lobar degeneration in particular.
His Internal medicine study incorporates themes from Endocrinology, Oncology and Genotype. He interconnects Episodic memory, Cognition, Cognitive impairment, Neuropsychology and Alzheimer's disease in the investigation of issues within Dementia. His Pathology research incorporates themes from Positron emission tomography, Multiple sclerosis and Magnetic resonance imaging.
His main research concerns Frontotemporal dementia, Internal medicine, Multiple sclerosis, Dementia and Disease. His Frontotemporal dementia research includes elements of Gene mutation, Neurology and Atrophy. His Internal medicine research incorporates elements of Gastroenterology, Endocrinology and Oncology.
His Multiple sclerosis research is multidisciplinary, incorporating perspectives in White matter, Virology and Cerebrospinal fluid, Pathology. His Dementia study integrates concerns from other disciplines, such as Psychiatry, Clinical trial, Neuropsychological assessment and Pathogenesis. His Disease research is multidisciplinary, relying on both Gene and Central nervous system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish.
Nature Genetics (2011)
Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease
Valentina Escott-Price;Céline Bellenguez;Li-San Wang;Seung-Hoan Choi.
PLOS ONE (2014)
Treatment of Alzheimer's disease; current status and new perspectives
Elio Scarpini;Philip Scheltens;Howard Feldman.
Lancet Neurology (2003)
APOE and Alzheimer disease: a major gene with semi-dominant inheritance
E Genin;D Hannequin;D Wallon;K Sleegers.
Molecular Psychiatry (2011)
Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
Lawrence S Honig;Bruno Vellas;Michael M Woodward;Mercè Boada.
The New England Journal of Medicine (2018)
Transcranial direct current stimulation improves recognition memory in Alzheimer disease
R. Ferrucci;F. Mameli;I. Guidi;S. Mrakic-Sposta.
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez.
Nature Genetics (2017)
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.
Howard H. Feldman;Steven Ferris;Bengt Winblad;Nikolaos Sfikas.
Lancet Neurology (2007)
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Niklas Mattsson;Ulf Andreasson;Staffan Persson;Hiroyuki Arai.
Alzheimers & Dementia (2011)
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis
Jonathan D Rohrer;Jennifer M Nicholas;Jennifer M Nicholas;David M Cash;John van Swieten.
Lancet Neurology (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: